Suppr超能文献

老年人抗生素相关性急性肾损伤:病例交叉研究。

Antibiotic-Associated Acute Kidney Injury Among Older Adults: A Case-Crossover Study.

机构信息

Department of Life Sciences, University of Bath, Bath, BA2 7AY, UK.

Department of Biochemistry, University of Otago, Dunedin, New Zealand.

出版信息

Clin Drug Investig. 2024 Feb;44(2):131-139. doi: 10.1007/s40261-023-01339-7. Epub 2024 Jan 3.

Abstract

BACKGROUND AND OBJECTIVES

Drug-related acute kidney injury is quite common in older adults. The associated drugs, including antibiotics, are often co-prescribed. The objective of this study was to ascertain antibiotic-associated acute kidney injury (AKI) in older adults aged 65 years or above in New Zealand using a case-crossover study design.

METHODS

The International Statistical Classification of Diseases and Related Health Problems, tenth revision, Australian modification code N17.x was used to identify all individuals aged 65 years and above with a diagnosis of incident AKI on admission between 1 January 2005 and 31 December 2020, from the New Zealand National Minimum Data Set. A case-crossover cohort for antibiotic exposures, with a 3 day case period and two 30 day washout periods, summed up to a 66 day study period, was created. Using conditional logistic regression, the changed odds of AKI due to exposure to an antibiotic was calculated as matched odds ratios and their 95% confidence intervals.

RESULTS

A total of 2399 incident cases of AKI were identified between 2005 and 2020 among older adults. The adjusted odds of consuming sulfamethoxazole/trimethoprim antibiotic during the case period was 3.57 times (95% CI 2.86-4.46) higher than the reference period among the incident AKI cases. Fluoroquinolone utilization was also associated with incident AKI (adjusted OR = 2.56; 95% CI 1.90-3.46).

CONCLUSION

The potential of sulfamethoxazole/trimethoprim and fluoroquinolones to be associated with AKI raises the significant need for vigilant prescribing of these antibiotics in older adults.

摘要

背景和目的

药物相关性急性肾损伤在老年人中较为常见。相关药物,包括抗生素,通常是同时开具的。本研究的目的是使用病例交叉研究设计,确定新西兰 65 岁及以上老年人中抗生素相关性急性肾损伤(AKI)。

方法

使用国际疾病分类第十版澳大利亚修改版 N17.x 代码,从新西兰国家最低数据集中确定所有在 2005 年 1 月 1 日至 2020 年 12 月 31 日期间因入院时新发 AKI 而诊断的 65 岁及以上个体。创建了一个抗生素暴露的病例交叉队列,有 3 天的病例期和两个 30 天的洗脱期,总计 66 天的研究期。使用条件逻辑回归,计算由于暴露于抗生素而导致 AKI 的改变的比值比及其 95%置信区间。

结果

在 2005 年至 2020 年间,共确定了 2399 例老年人新发 AKI 病例。与参考期相比,在 AKI 发病期间,磺胺甲恶唑/甲氧苄啶抗生素的调整比值比为 3.57 倍(95%CI 2.86-4.46)。氟喹诺酮类药物的使用也与 AKI 有关(调整 OR=2.56;95%CI 1.90-3.46)。

结论

磺胺甲恶唑/甲氧苄啶和氟喹诺酮类药物与 AKI 相关的可能性增加了这些抗生素在老年人中谨慎处方的重要性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验